A survey of peptides with effective therapeutic potential in Alzheimer's disease rodent models or in human clinical studies.
about
Preclinical Pharmacokinetic Studies of the Tritium Labelled D-Enantiomeric Peptide D3 Developed for the Treatment of Alzheimer´s DiseaseCritique of the use of fluorescence-based reporters in Escherichia coli as a screening tool for the identification of peptide inhibitors of Aβ42 aggregation.Targeting the cyclin-binding groove site to inhibit the catalytic activity of CDK2/cyclin A complex using p27(KIP1)-derived peptidomimetic inhibitorsPeptide regulation of cofilin activity in the CNS: A novel therapeutic approach for treatment of multiple neurological disorders.Scrutiny of the mechanism of small molecule inhibitor preventing conformational transition of amyloid-β42 monomer: insights from molecular dynamics simulations.Pharmacokinetic Properties of a Novel D-Peptide Developed to be Therapeutically Active Against Toxic β-Amyloid Oligomers.
P2860
A survey of peptides with effective therapeutic potential in Alzheimer's disease rodent models or in human clinical studies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A survey of peptides with effe ...... or in human clinical studies.
@en
A survey of peptides with effe ...... or in human clinical studies.
@nl
type
label
A survey of peptides with effe ...... or in human clinical studies.
@en
A survey of peptides with effe ...... or in human clinical studies.
@nl
prefLabel
A survey of peptides with effe ...... or in human clinical studies.
@en
A survey of peptides with effe ...... or in human clinical studies.
@nl
P2860
P1476
A survey of peptides with effe ...... or in human clinical studies.
@en
P2860
P304
P356
10.2174/138955712800493942
P5008
P577
2012-05-01T00:00:00Z